GlassScriptPhysician profile
Tiffany B Genewick
NPI 1144278664
$2,123.16
in general payments reported to CMS, 2019-2025
21 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $232 · 2021: $269 · 2022: $331 · 2023: $392 · 2024: $353 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.50 |
| Education | $282.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $541.86 | 2023-2025 | Veozah |
| Pfizer INC. | $337.06 | 2019-2024 | |
| Allergan, INC. | $161.98 | 2019-2020 | |
| Abbvie INC. | $130.86 | 2021-2022 | |
| Therapeuticsmd, INC. | $118.82 | 2019-2022 | |
| Exeltis, USA INC. | $105.32 | 2022-2024 | Slynd |
| Revance Therapeutics, INC. | $90.04 | 2024-2025 | Daxxify |
| Scynexis, INC. | $81.17 | 2022 | |
| Exact Sciences Corporation | $73.33 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $72.57 | 2021-2025 | Prolia, Evenity |
| Mayne Pharma Commercial LLC | $70.63 | 2023 | |
| Mylan Pharmaceuticals INC. | $57.51 | 2021-2022 | |
| Merz North America, INC. | $55.30 | 2023 | Xeomin |
| Agile Therapeutics, INC. | $55.18 | 2021-2022 | |
| Novo Nordisk INC | $47.10 | 2023-2024 | Wegovy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $28.00 | 2019-2020 | |
| Becton, Dickinson and Company | $21.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.41 | 2025 | |
| Lilly USA, LLC | $20.49 | 2025 | Zepbound, Mounjaro |
| Daiichi Sankyo INC. | $17.75 | 2022 | |
| Hologic Sales and Service, LLC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Genewick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.